Patents by Inventor So Young KI

So Young KI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compound as a protein kinase inhibitor
    Patent number: 11524968
    Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: December 13, 2022
    Assignee: HK inno.N Corporation
    Inventors: Hyuk Woo Lee, Mi Kyung Ji, Seung Chan Kim, Ha Na Yu, Soo Yeon Jung, Ji-Yeon Park, Ye-Lim Lee, Ho-Youl Lee, So Young Ki, Dongkyu Kim, Myeongjoong Kim
  • NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF
    Publication number: 20220009902
    Abstract: The present invention provides a novel compound having a protein kinase inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof. The compound according to the present invention, stereoisomers thereof or pharmaceutically acceptable salts thereof are effective in preventing or treating protein kinase-related diseases such as cancers, autoimmune diseases, neurological diseases, metabolic diseases, infections or the like by showing a protein kinase inhibitory activity.
    Type: Application
    Filed: November 14, 2019
    Publication date: January 13, 2022
    Inventors: Ji-Yeon Park, Seung Chan Kim, So Young Ki, Ye-Ri Shim
  • Use of aminoalkylbenzothiazepine derivatives
    Patent number: 11202783
    Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: December 21, 2021
    Assignee: CJ Healthcare Corporation
    Inventors: Hyungjin Jun, So Young Ki, Keunho Lee, Jin Woo Jung, Dong Hyun Kim, Chi Hye Park, Hyoung Rok Bak, Shin-Young Ryu, Ju Hyun Lee, Ho-Youl Lee, Won-Hyuk Jung, Dong Hyun Ko, Seungin Kim, Joonseok Byun, Jae Ho Yoo, Seunghee Ji
  • Heterocyclic Compound as a Protein Kinase Inhibitor
    Publication number: 20210171544
    Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.
    Type: Application
    Filed: October 17, 2018
    Publication date: June 10, 2021
    Inventors: Hyuk Woo Lee, Mi Kyung Ji, Seung Chan Kim, Ha Na Yu, Soo Yeon Jung, Ji-Yeon Park, Ye-Lim Lee, Ho-Youl Lee, So Young KI, Dongkyu Kim, Myeongjoong Kim
  • USE OF AMINOALKYLBENZOTHIAZEPINE DERIVATIVES
    Publication number: 20200147101
    Abstract: The present disclosure relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: July 20, 2018
    Publication date: May 14, 2020
    Applicant: CJ Healthcare Corporation
    Inventors: Hyungjin Jun, So Young Ki, Keunho Lee, Jin Woo Jung, Dong Hyun Kim, Chi Hye Park, Hyoung Rok Bak, Shin-Young Ryu, Ju Hyun Lee, Ho-Youl Lee, Won-Hyuk Jung, Dong Hyun Ko, Seungin Kim, Joonseok Byun, Jae Ho Yoo, Seunghee Ji
  • Protein kinase inhibitor containing pyrrolopyridazine derivative
    Patent number: 9815840
    Abstract: The present invention relates to a pyrrolopyridazine derivative represented by Formula 1 of the detailed description, or a pharmaceutically acceptable salt thereof. The compound according to the present invention and a pharmaceutically acceptable salt thereof can inhibit the activity of protein kinase(s), and thus are useful for preventing or treating diseases related thereto.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: November 14, 2017
    Assignee: The Asan Foundation
    Inventors: Tae Gon Baik, Won-Hyuk Jung, Seung In Kim, Seung Chan Kim, Sook Kyung Park, Su Yeon Jung, Seung Hee Ji, So Young Ki, Min Cheol Kim, Eun Young Lee, Eun Mi Hong
  • PROTEIN KINASE INHIBITOR CONTAINING PYRROLOPYRIDAZINE DERIVATIVE
    Publication number: 20160207931
    Abstract: The present invention relates to a pyrrolopyridazine derivative represented by Formula 1 of the detailed description, or a pharmaceutically acceptable salt thereof. The compound according to the present invention and a pharmaceutically acceptable salt thereof can inhibit the activity of protein kinase(s), and thus are useful for preventing or treating diseases related thereto.
    Type: Application
    Filed: August 29, 2014
    Publication date: July 21, 2016
    Applicant: CJ Healthcare Corporation
    Inventors: Tae Gon BAIK, Won-Hyuk JUNG, Seung In KIM, Seung Chan KIM, Sook Kyung PARK, Su Yeon JUNG, Seung Hee JI, So Young KI, Min Cheol KIM, Eun Young LEE, Eun Mi HONG